Axial Spondyloarthritis
📧 Sign up to get email alerts when something new happens for Axial Spondyloarthritis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2025-03-26FDA Approved: RINVOQ — Supplemental Application (AbbVie Inc.)
FDA approved AbbVie’s supplemental application for Rinvoq (upadacitinib), resulting in a labeling update for the product.